NORTHERN TRUST CORP - UNUM THERAPEUTICS INC ownership

UNUM THERAPEUTICS INC's ticker is UMRX and the CUSIP is 903214104. A total of 25 filers reported holding UNUM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of UNUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$65,000
+550.0%
27,710
+28.5%
0.00%
Q2 2020$10,000
+11.1%
21,5640.0%0.00%
Q1 2020$9,000
+12.5%
21,564
+84.0%
0.00%
Q4 2019$8,000
-52.9%
11,7210.0%0.00%
Q3 2019$17,000
-96.3%
11,721
-93.3%
0.00%
Q2 2019$459,000
-44.4%
175,290
-6.8%
0.00%
Q1 2019$826,000
+5.1%
188,041
+5.3%
0.00%
Q4 2018$786,000
+76.2%
178,640
+312.6%
0.00%
Q3 2018$446,000
-28.1%
43,295
+0.1%
0.00%
Q2 2018$620,00043,2320.00%
Other shareholders
UNUM THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 3,361,535$4,840,0007.97%
CHI Advisors LLC 790,805$1,139,0001.11%
New Leaf Venture Partners, L.L.C. 1,795,545$2,586,0000.78%
SECTORAL ASSET MANAGEMENT INC 1,519,174$2,188,0000.38%
Novo Holdings A/S 473,441$682,0000.12%
WEDBUSH SECURITIES INC 33,135$48,0000.01%
OXFORD ASSET MANAGEMENT LLP 100,000$144,0000.00%
WASATCH ADVISORS LP 254,449$366,0000.00%
Tower Research Capital LLC (TRC) 21,602$31,0000.00%
FIL Ltd 783,423$1,128,0000.00%
View complete list of UNUM THERAPEUTICS INC shareholders